share print

lorem ipsum

sous-titre optionnel

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis malesuada ipsum dolor sit et diam consectutre lacus quis massa laoreet bibendum. duis tempus enim sit amet sed diam et consectuter erat.

Andre Ulmann

André ULMANN

FOUNDER OF HRA PHARMA

Role at HRA Pharma: André Ulmann is the Founder of HRA Pharma and Chairman of its Board of Directors, a position he has held since 2009.

Other activities: André Ulmann currently serves as a consultant for several start-up companies (AmmTek, Maia Woundcare, Physip, LTK) and a non-profit, non-governmental organization focused on reproductive health.

Professional background: André Ulmann was CEO of HRA Pharma from 1996 to 2009. Under his leadership, HRA Pharma developed into a pharmaceutical leader in emergency contraception and orphan diseases. Before founding HRA Pharma, André Ulmann served as Medical Director and Head of Clinical Research for Roussel-Uclaf and Hoechst-Marion-Roussel with global responsibility in the fields of endocrinology, immunology, neurobiology, and bone diseases. Prior to that, he was international project leader for the development of RU 486, then medical director of Laboratoire Roussel, France. He began his career with seven years' practice as a physician at the Necker Hospital of Paris. André Ulmann holds an M.D. degree from the University of Paris VII, France. He was awarded with a Ph.D. in science from the University of Paris VI, France.

Key knowledge: André Ulmann's areas of specialization include corporate governance and strategy, healthcare management and project management.

Andre Ulmann

André ULMANN

USA Italy

FOUNDER OF HRA PHARMA

Role at HRA Pharma: André Ulmann is the Founder of HRA Pharma and Chairman of its Board of Directors, a position he has held since 2009.
Other activities: André Ulmann currently serves as a consultant for several start-up companies (AmmTek, Maia Woundcare, Physip, LTK) and a non-profit, non-governmental organization focused on reproductive health.
Christine VACHEZ

Christine VACHEZ

FOUNDER OF HRA PHARMA

Role at HRA Pharma: Christine Vacher has been a member of the Board of Directors since March 2012.

Other activities: Ms. Vacher is consultant at Axoma Consultants. With over two decades of experience in strategy and management consulting.

Professional background: André Ulmann was CEO of HRA Pharma from 1996 to 2009. Under his leadership, HRA Pharma developed into a pharmaceutical leader in emergency contraception and orphan diseases. Before founding HRA Pharma, André Ulmann served as Medical Director and Head of Clinical Research for Roussel-Uclaf and Hoechst-Marion-Roussel with global responsibility in the fields of endocrinology, immunology, neurobiology, and bone diseases. Prior to that, he was international project leader for the development of RU 486, then medical director of Laboratoire Roussel, France. He began his career with seven years' practice as a physician at the Necker Hospital of Paris. André Ulmann holds an M.D. degree from the University of Paris VII, France. He was awarded with a Ph.D. in science from the University of Paris VI, France.

Key knowledge: André Ulmann's areas of specialization include corporate governance and strategy, healthcare management and project management.

Andre Ulmann

André ULMANN

USA Italy

FOUNDER OF HRA PHARMA

Role at HRA Pharma: André Ulmann is the Founder of HRA Pharma and Chairman of its Board of Directors, a position he has held since 2009.
Other activities: André Ulmann currently serves as a consultant for several start-up companies (AmmTek, Maia Woundcare, Physip, LTK) and a non-profit, non-governmental organization focused on reproductive health.
Nicolas TURNER

Nicolas TURNER

FOUNDER OF HRA PHARMA

Role at HRA Pharma: Nicholas Turner has been a member of the Board of Directors since 2006.

Other activities: Mr. Turner is an advisor to a G30 member led organisation involved in financing economic development projects.

Professional background: André Ulmann was CEO of HRA Pharma from 1996 to 2009. Under his leadership, HRA Pharma developed into a pharmaceutical leader in emergency contraception and orphan diseases. Before founding HRA Pharma, André Ulmann served as Medical Director and Head of Clinical Research for Roussel-Uclaf and Hoechst-Marion-Roussel with global responsibility in the fields of endocrinology, immunology, neurobiology, and bone diseases. Prior to that, he was international project leader for the development of RU 486, then medical director of Laboratoire Roussel, France. He began his career with seven years' practice as a physician at the Necker Hospital of Paris. André Ulmann holds an M.D. degree from the University of Paris VII, France. He was awarded with a Ph.D. in science from the University of Paris VI, France.

Key knowledge: André Ulmann's areas of specialization include corporate governance and strategy, healthcare management and project management.

Andre Ulmann

André ULMANN

USA Italy

FOUNDER OF HRA PHARMA

Role at HRA Pharma: André Ulmann is the Founder of HRA Pharma and Chairman of its Board of Directors, a position he has held since 2009.
Other activities: André Ulmann currently serves as a consultant for several start-up companies (AmmTek, Maia Woundcare, Physip, LTK) and a non-profit, non-governmental organization focused on reproductive health.
Karsten LANGER

Karsten LANGER

FOUNDER OF HRA PHARMA

Role at HRA Pharma: Karsten Langer has been a member of the Board of Directors since November 2011.

Other activities: Mr. Langer is a Brussels-based partner at the Riverside Company. He heads Riverside's investment activities in France and the Benelux region. In addition, Mr. Langer was Chairman.

Professional background: André Ulmann was CEO of HRA Pharma from 1996 to 2009. Under his leadership, HRA Pharma developed into a pharmaceutical leader in emergency contraception and orphan diseases. Before founding HRA Pharma, André Ulmann served as Medical Director and Head of Clinical Research for Roussel-Uclaf and Hoechst-Marion-Roussel with global responsibility in the fields of endocrinology, immunology, neurobiology, and bone diseases. Prior to that, he was international project leader for the development of RU 486, then medical director of Laboratoire Roussel, France. He began his career with seven years' practice as a physician at the Necker Hospital of Paris. André Ulmann holds an M.D. degree from the University of Paris VII, France. He was awarded with a Ph.D. in science from the University of Paris VI, France.

Key knowledge: André Ulmann's areas of specialization include corporate governance and strategy, healthcare management and project management.

Andre Ulmann

André ULMANN

USA Italy

FOUNDER OF HRA PHARMA

Role at HRA Pharma: André Ulmann is the Founder of HRA Pharma and Chairman of its Board of Directors, a position he has held since 2009.
Other activities: André Ulmann currently serves as a consultant for several start-up companies (AmmTek, Maia Woundcare, Physip, LTK) and a non-profit, non-governmental organization focused on reproductive health.
Torsten HOOF

Torsten HOOF

FOUNDER OF HRA PHARMA

Role at HRA Pharma: Role at HRA Pharma: Torsten Hoof joined the Board of Directors in December 2011.

Other activities: Torsten Hoof is currently a partner at Lumitereo, a strategic consultancy firm based in Switzerland providing services to Pharma and Biotech companies.

Professional background: André Ulmann was CEO of HRA Pharma from 1996 to 2009. Under his leadership, HRA Pharma developed into a pharmaceutical leader in emergency contraception and orphan diseases. Before founding HRA Pharma, André Ulmann served as Medical Director and Head of Clinical Research for Roussel-Uclaf and Hoechst-Marion-Roussel with global responsibility in the fields of endocrinology, immunology, neurobiology, and bone diseases. Prior to that, he was international project leader for the development of RU 486, then medical director of Laboratoire Roussel, France. He began his career with seven years' practice as a physician at the Necker Hospital of Paris. André Ulmann holds an M.D. degree from the University of Paris VII, France. He was awarded with a Ph.D. in science from the University of Paris VI, France.

Key knowledge: André Ulmann's areas of specialization include corporate governance and strategy, healthcare management and project management.

Andre Ulmann

André ULMANN

USA Italy

FOUNDER OF HRA PHARMA

Role at HRA Pharma: André Ulmann is the Founder of HRA Pharma and Chairman of its Board of Directors, a position he has held since 2009.
Other activities: André Ulmann currently serves as a consultant for several start-up companies (AmmTek, Maia Woundcare, Physip, LTK) and a non-profit, non-governmental organization focused on reproductive health.
Torsten HOOF

Catherine DUNAN

FOUNDER OF HRA PHARMA

Role at HRA Pharma: Role at HRA Pharma: Torsten Hoof joined the Board of Directors in December 2011.

Other activities: Role at HRA Pharma: Torsten Hoof joined the Board of Directors in December 2011.

Professional background: André Ulmann was CEO of HRA Pharma from 1996 to 2009. Under his leadership, HRA Pharma developed into a pharmaceutical leader in emergency contraception and orphan diseases. Before founding HRA Pharma, André Ulmann served as Medical Director and Head of Clinical Research for Roussel-Uclaf and Hoechst-Marion-Roussel with global responsibility in the fields of endocrinology, immunology, neurobiology, and bone diseases. Prior to that, he was international project leader for the development of RU 486, then medical director of Laboratoire Roussel, France. He began his career with seven years' practice as a physician at the Necker Hospital of Paris. André Ulmann holds an M.D. degree from the University of Paris VII, France. He was awarded with a Ph.D. in science from the University of Paris VI, France.

Key knowledge: André Ulmann's areas of specialization include corporate governance and strategy, healthcare management and project management.

Andre Ulmann

André ULMANN

USA Italy

FOUNDER OF HRA PHARMA

Role at HRA Pharma: André Ulmann is the Founder of HRA Pharma and Chairman of its Board of Directors, a position he has held since 2009.
Other activities: André Ulmann currently serves as a consultant for several start-up companies (AmmTek, Maia Woundcare, Physip, LTK) and a non-profit, non-governmental organization focused on reproductive health.